Skip to content

Polaryx Therapeutics, Inc. PLYX Net Operating Loss Carryforwards

Net Operating Loss Carryforwards at other companies

Service Corporation International logo
Service Corporation InternationalSCI
$2.21B-6.2%
Curtiss-Wright logo
Curtiss-WrightCW
$21.3M+15.1%
Stifel Financial logo
Stifel FinancialSF
$120.7M-24.3%
Fluor logo
FluorFLR
$331M-50.1%
Ralliant Corporation logo
Ralliant CorporationRAL
$97.7M
SBA Communications logo
SBA CommunicationsSBAC
$366.2M-3.1%

Other financials

Income statement

See full
Operating income-$2.0M+61.2%
Net income-$2.5M+49.6%
EPS (diluted)-$0.05+54.5%

Balance sheet

See full
Cash & equivalents$3.1M+1,132%
Total equity$2.5M-41.5%
Total assets$3.5M

Cash flow

See full
Operating cash flow-$2.1M-191%

Valuation

See full
Market cap$115.64M

Returns & leverage

See full
Return on equity-1,209.8%
Current ratio3.5×

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLossCarryforwards.

The official record: Polaryx Therapeutics, Inc. ’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's net operating loss carryforwards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's net operating loss carryforwards?
Polaryx Therapeutics, Inc. (PLYX) reported net operating loss carryforwards of $18.7M in Q4 2025.
What does net operating loss carryforwards mean?
These are tax assets representing losses that can be used to reduce taxable income in future periods. They provide a potential future tax shield, improving cash flow by lowering future tax payments. Investors monitor these to estimate the duration and magnitude of potential tax savings.